Skip to main content
Have a personal or library account? Click to login
Methylphenidate for ADHD in Children and Adolescents Cover

Methylphenidate for ADHD in Children and Adolescents

Open Access
|Mar 1998

Abstract

The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivity disorder (ADHD) was compared during childhood (ages 8 to 11 years) and adolescence (ages 12 to 14.5 years) in a retrospective follow-up study of 16 patients who had completed double-blind, placebo-controlled, crossover trials during two separate summer treatment programs at the Western Psychiatric Institute, University of Pittsburgh Medical Center, PA.
Language: English
Page range: 23 - 24
Published on: Mar 1, 1998
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 1998 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.